Turn Therapeutics (TTRX) Shares Outstanding (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Shares Outstanding (Entity) of $29.8 million for Q1 2026, up 9.29% year-over-year from $27.3 million in Q1 2025, and up 1.16% quarter-over-quarter from $29.4 million in Q4 2025.
Turn Therapeutics (TTRX) Shares Outstanding (2024 - 2026) Analysis & Trends
Turn Therapeutics' Shares Outstanding (Entity) history runs 3 years deep, the most recent figure standing at $29.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 9.29% year-over-year to $29.8 million; the TTM figure through Mar 2026 stood at $29.8 million (up 9.29% YoY), while the FY2025 annual figure was $29.4 million, up 9.68% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $29.8 million, up from $29.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $29.8 million in Q1 2026, with the low at $26.7 million in Q3 2024.
- The 3-year median for Shares Outstanding (Entity) is $27.6 million (2025), against an average of $28.0 million.
- Peak annual rise in Shares Outstanding (Entity) reached 9.68% in 2025, while the deepest fall reached 4.99% in 2025.
- Turn Therapeutics' Shares Outstanding (Entity) stood at $26.8 million in 2024, then increased by 9.68% to $29.4 million in 2025, then increased by 1.16% to $29.8 million in 2026.
- Business Quant data shows TTRX's Shares Outstanding (Entity) at $29.8 million in Q1 2026, $29.4 million in Q4 2025, and $28.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Turn Therapeutics | 285.07 Mn | 285.07 Mn | - | 29.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.48 Mn |
| Mar 31, 2026 | 29.48 Mn |
| Dec 31, 2025 | 27.72 Mn |
| Sep 30, 2025 | 27.98 Mn |
| Mar 31, 2025 | 26.96 Mn |
| Dec 31, 2024 | 26.64 Mn |
| Sep 30, 2024 | 26.65 Mn |